I wrote about RSV vaccines in my #NatureMedicine column in February.
Very good news this week with the FDA approval of GSK's RSV vaccine for adults 60 and over - it's the first approved RSV vaccine.

https://edition.cnn.com/2023/05/03/health/first-rsv-vaccine-approved/index.html

Several other candidate RSV vaccines are at a late stage of development, including mRNA based vaccines. The next big thing to watch for are those seeking to protect newborns and infants by maternal immunisation.

#RSV #Vaccine #RespiratoryVirus #drugdevelopment #Pharma #Immunology

https://www.nature.com/articles/d41591-023-00017-7